Valuation: Thyrocare Technologies Limited

Market Cap 90.97B 950M 828M 780M 710M 1.33B 1.33B 9.34B 3.6B 46.34B 3.57B 3.49B 150B P/E 2027 *
43.5x
P/E 2028 * 35.4x
Enterprise Value 90.97B 950M 828M 780M 710M 1.33B 1.33B 9.34B 3.6B 46.34B 3.57B 3.49B 150B EV / Sales 2027 *
9.13x
EV / Sales 2028 * 7.75x
Free-Float
48.82%
Yield 2027 *
1.92%
Yield 2028 * 2.23%
1 day+0.98%
1 week+5.98%
Current month-3.98%
1 month-1.21%
3 months+5.96%
6 months+54.73%
Current year+29.41%
1 week 533.25
Extreme 533.25
593.25
1 month 533.25
Extreme 533.25
611.55
Current year 342.55
Extreme 342.55
662
1 year 342.55
Extreme 342.55
662
3 years 170.33
Extreme 170.333333
662
5 years 138.67
Extreme 138.666666
662
10 years 135.55
Extreme 135.549999
662
Manager TitleAgeSince
Chief Executive Officer 48 2022-05-03
Director of Finance/CFO - 2025-07-23
Chief Operating Officer - 2025-12-17
Director TitleAgeSince
Director/Board Member - 2017-08-11
Chairman 48 -
Director/Board Member - 2023-07-13
Date Insider Type Main position Quantity % Market Cap. Importance
1/31/25 Buy 200 0.0004%
1/31/25 Buy 555 0.0010%
1/31/25 Buy 245 0.0005%
Change 5-day change 1-year change 3-year change Capi.($)
+0.98%+5.98%+42.13%+207.05% 950M
+0.34%+8.44%+104.65%+683.76% 53.43B
+0.09%+1.80%+15.77%+56.47% 26.03B
-1.75%-1.14%-14.02%-37.48% 6.85B
-4.38%-3.74%-4.93%+166.19% 5.72B
-0.55%+0.18%+12.72%+63.26% 3.35B
-3.23%+9.01%-24.52%+2,580.27% 2.92B
-2.51%+5.43%+127.82%+59.10% 2.49B
+2.81%+2.71%+37.63%+47.22% 2.34B
+2.68%+4.66%-6.29%-53.90% 1.96B
Average -0.71%+3.76%+29.10%+377.19% 10.6B
Weighted average by Cap. -1.01%+5.25%+59.25%+441.18%

Financials

2027 *2028 *
Net sales 9.97B 104M 90.72M 85.45M 77.82M 146M 146M 1.02B 394M 5.08B 391M 382M 16.39B 11.73B 122M 107M 101M 91.58M 172M 172M 1.2B 464M 5.98B 460M 450M 19.28B
Net income 2.05B 21.36M 18.62M 17.54M 15.97M 29.95M 29.99M 210M 80.96M 1.04B 80.23M 78.45M 3.36B 2.53B 26.43M 23.04M 21.7M 19.77M 37.06M 37.1M 260M 100M 1.29B 99.28M 97.08M 4.16B
Net Debt - -
Logo Thyrocare Technologies Limited
Thyrocare Technologies Limited is an India-based company, which operates as a healthcare services provider. It offers a range of diagnostic and related healthcare tests and services that are focused on early detection, preventive care, and ongoing disease monitoring. Its segments include diagnostic testing services, Imaging Services, and others. The Diagnostic Testing Services segment includes diagnostic and testing services, selling of consumables used for collection and promotion of pathology. The Imaging Services include diagnostic and imaging services, the selling of radiopharmaceuticals, and consumables for reporting. The Others segment includes the sale of testing equipment and consumables, and the selling of glucometer and glucostrips under the brand, Sugarscan. It has a centralized fully automated diagnostic testing laboratory, regional processing laboratories, and a medical cyclotron facility across India. It is also focused on offering pathological services.
Employees
1,906
Date Price Change Volume
26-09-22 577.15 +0.98% 37,693
26-09-21 ₹571.55 +2.82% 122,817
26-09-18 ₹555.90 -0.72% 12,117
26-09-17 ₹559.95 +3.76% 8,123
26-09-16 ₹539.65 -0.91% 16,154
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
571.55INR
Average target price
671.00INR
Spread / Average Target
+17.40%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. THYROCARE Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!